Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-1.7%Return on Equity
VS
Market
Sector
Industry
History
$ 3.95Close
$ 2.42 - $ 7.4 52-Week Range
Ticker Information
Ticker
CTKBCompany Name
CYTEK BIOSCIENCES INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQCYTEK BIOSCIENCES INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTKB - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 377.56M | $ -6.4M | -1.7% |
| 3/31/2025 | $ 379.62M | $ -11.25M | -2.96% |
| 12/31/2024 | $ 395.74M | $ -6.02M | -1.52% |
| 9/30/2024 | $ 385.46M | $ -10.16M | -2.64% |
| 6/30/2024 | $ 389.12M | $ -17.56M | -4.51% |
| 3/31/2024 | $ 392.61M | $ -11.51M | -2.93% |
| 12/31/2023 | $ 393.06M | $ -12.15M | -3.09% |
| 9/30/2023 | $ 415.52M | $ -14.12M | -3.4% |
| 6/30/2023 | $ 424.18M | $ -6M | -1.41% |
| 3/31/2023 | $ 423.46M | $ -2.21M | -0.52% |
Key Performance Insights, Last 5 Years
- CYTEK BIOSCIENCES INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, CYTEK BIOSCIENCES INC's average ROE has been -1.68%.
- The median ROE for CYTEK BIOSCIENCES INC during this period was -1.52%
- CYTEK BIOSCIENCES INC reached its highest ROE over the past 5 years at 0.61%.
- The lowest ROE recorded by CYTEK BIOSCIENCES INC in the same timeframe -4.51%
CYTEK BIOSCIENCES INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CYTEK BIOSCIENCES INC is calculated as follows: Net Inc. Cmn. [ $ 3.22M ] / Equity [ $ -16.03M ]
(=) ROE [ 0% ] CTKB - Return on Equity, Last 5 years
-4.51%
Minimum
Jun 30, 2024
0.61%
Maximum
Dec 31, 2022
-1.68%
Average
-1.52%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |